Digital health company Akili is on the brink of its first major expansion beyond the US, partnering with Shionogi to file a localised version of its attention deficit hyperactivity disorder (ADHD ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict Here's a roundup of top developments ...

DWS CROCI International Fund earns a Below Average Process Pillar rating. The process is bolstered by the stability of the management team. Specifically, the fund has not seen a manager change in ...

6479.T MINEBEA MITSUMI Inc.

See Shionogi & Co., Ltd. (SGIOY) history of stock splits. Includes date and ratio. Skip to content Home page Seeking Alpha - Power to Investors About Premium Explore Alpha Picks Home Stock Analysis ...

Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional ...